AP-III-a4 hydrochloride
CAS No. 2070014-95-6
AP-III-a4 hydrochloride( ENOblock hydrochloride )
Catalog No. M25058 CAS No. 2070014-95-6
AP-III-a4 (ENOblock) hydrochloride is a nonsubstrate analogue enolase inhibitor with an IC50 of 0.576 uM. AP-III-a4 hydrochloride can be used for the research of cancer and diabetic.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAP-III-a4 hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionAP-III-a4 (ENOblock) hydrochloride is a nonsubstrate analogue enolase inhibitor with an IC50 of 0.576 uM. AP-III-a4 hydrochloride can be used for the research of cancer and diabetic.
-
DescriptionAP-III-a4 (ENOblock) hydrochloride is a nonsubstrate analogue enolase inhibitor with an IC50 of 0.576 uM. AP-III-a4 hydrochloride can be used for the research of cancer and diabetic.AP-III-a4 (ENOblock) (0-10 μM; 24 h) inhibits HCT116 cell viability in a dose-dependent manner.AP-III-a4 directly binds to enolase and inhibits its activity.AP-III-a4 (0-10 μM; 24 or 48 h) inhibits cancer cell migration and invasion, induces cancer cell apoptosis.AP-III-a4 (10 μM; 24 h) can induce glucose uptake and inhibit phosphoenolpyruvate carboxykinase (PEPCK) expression in hepatocytes and kidney cells.
-
In VitroCell Viability Assay Cell Line:HCT116 Concentration:1.25, 2.5, 5 and 10 μM Incubation Time:24 h Result:Induced higher levels of HCT116 colon cancer cell death in hypoxic conditions compared to normoxia.Western Blot Analysis Cell Line:HCT116 Concentration:1.25, 2.5, 5 and 10 μM Incubation Time:24 h for AKT, 48 h for Bcl-Xl Result:Bound to enolase in cell lysate and bound to purified enolase. Decreased the expression of AKT and Bcl-Xl, which are negative regulators of apoptosis.Cell Invasion Assay Cell Line:HCT116 Concentration:0.156, 0.312, 0.625, 1.25 and 2.5 μM Incubation Time:24 h Result:Significantly inhibits cancer cell invasion at a treatment concentration of 0.625 μM.Cell Migration Assay Cell Line:HCT116 Concentration:0.625, 1.25 and 2.5 μM Incubation Time:24 h esult:Inhibited cell migration dose-dependently.RT-PCR Cell Line:Huh7 and HEK Concentration:10 μM Incubation Time:24 hResult:Induced glucose uptake and inhibited PEPCK expression.
-
In VivoAnimal Model:The zebrafish cancer cell HCT116 xenograft model Dosage:10 μM Administration:96 h Result:Reduced cancer cell dissemination. Inhibited PEPCK expression and induced glucose uptake. Inhibited adipogenesis and foam cell formation.
-
SynonymsENOblock hydrochloride
-
PathwayApoptosis
-
TargetApoptosis
-
RecptorIC50: 0.576 uM (enolase)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2070014-95-6
-
Formula Weight631.18
-
Molecular FormulaC31H44ClFN8O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : ≥ 53 mg/mL (83.97 mM)
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Da-Woon Jung, et al. A Unique Small Molecule Inhibitor of Enolase Clarifies Its Role in Fundamental Biological Processes.ACS Chem. Biol., 2013, 8 (6), pp 1271–1282 [Content Brief]
molnova catalog
related products
-
DCH36_06
DCH36_06? as a bona fide is a potent p300/CBP inhibitor
-
Fluorizoline
Fluorizoline is a PHB-binding compound with anticancer and antiproliferative activity that induces apoptosis by inducing selective targeting of the BH3 protein NOXA to PHB.Fluorizoline inhibits protein synthesis and has been used in studies of leukemia.
-
Epristeride
Epristeride (ONO-9302) is an orally active, selective and non-competitive steroidal 5-α-reductase isoform 2 inhibitor that inhibits SR isoform 2.
Cart
sales@molnova.com